The supplied evidence records do not address mitochondrial transfer therapy for infertility. They cover skeletal muscle ankyrin-B/fission , tumor mitochondrial biochemistry, fish ROS, MAMs, ischemia-reperfusion, calcium buffering, ultrastructure, and nitric oxide inhibition β none contain live-birth data for heterologous vs autologous mitochondria replacement in ART.
What is missing to run this meta-analysis: patient-level or aggregate live-birth rates, embryo transfer outcomes, donor-source definition (heterologous donor oocyte/blastocyst vs autologous), comparator arms, and study identifiers for trials of mitochondrial replacement or cytoplasmic transfer in infertility. No such evidence units were supplied, so no effect estimate or graph can be honestly produced from the provided data.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.